2009
DOI: 10.1016/j.surneu.2008.04.021
|View full text |Cite
|
Sign up to set email alerts
|

Nonaneurysmal nonperimesencephalic subarachnoid hemorrhage: is it a benign entity?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

7
56
0

Year Published

2009
2009
2018
2018

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 59 publications
(63 citation statements)
references
References 22 publications
7
56
0
Order By: Relevance
“…Patients with NNSAH tend to be male, younger and less hypertensive compared with those with aneurysmal SAH according to the current literature (6,13,23,42,52). The agerelated epidemiological data of our study cohort was in line with that of existing literature (mean age of 51 years); however, our study found no gender predominancy (51% to 49%).…”
Section: █ Resultssupporting
confidence: 88%
See 2 more Smart Citations
“…Patients with NNSAH tend to be male, younger and less hypertensive compared with those with aneurysmal SAH according to the current literature (6,13,23,42,52). The agerelated epidemiological data of our study cohort was in line with that of existing literature (mean age of 51 years); however, our study found no gender predominancy (51% to 49%).…”
Section: █ Resultssupporting
confidence: 88%
“…Among these bleeding patterns, pure perimesencephalic (PM) SAH is associated with lower complication rates, mild clinical course and better outcomes (3,4,23). PM-SAH was first defined by van Gijn et al (55), and approximately one third to two thirds of these patients were reported to have this bleeding pattern (18,23,29).…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…The risk of rebleeding and especially the risk of developing cerebral vasospasm (CVS) seem to be negligible. 1,2,5,6 In contrast, patients with non-pmSAH are reported to suffer from a higher risk of a complicated clinical course, development of CVS and subsequent worse outcome. 1, 4,6,7 Inflammatory response with cytokine release is associated with severity of illness, clinical outcome and occurrence of CVS in patients with aSAH.…”
Section: Introductionmentioning
confidence: 99%
“…1,2,5,6 In contrast, patients with non-pmSAH are reported to suffer from a higher risk of a complicated clinical course, development of CVS and subsequent worse outcome. 1, 4,6,7 Inflammatory response with cytokine release is associated with severity of illness, clinical outcome and occurrence of CVS in patients with aSAH. [8][9][10] Higher levels of interleukin (IL)-6 in the cerebro-spinal fluid (CSF) have been linked to the occurrence of CVS and worse outcome.…”
Section: Introductionmentioning
confidence: 99%